http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103808937-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-365 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
filingDate | 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103808937-B |
titleOfInvention | For breast cancer early metaphase quick diagnosis reagent kit and detection method thereof |
abstract | The invention discloses a kind of for breast cancer early metaphase quick diagnosis reagent kit, comprise capture antibody, described capture antibody comprises the monoclonal antibody that galactose agglutinin, PUM and human aspartyl's B-hydroxylase obtain respectively; Described kit also comprises detection antibody, and described detection antibody comprises the polyclonal antibody that galactose agglutinin, PUM and human aspartyl's B-hydroxylase obtain respectively.Beneficial effect of the present invention is as follows: have the advantages that highly sensitive accuracy is strong, and its sensitivity and accuracy all reach more than 90%. |
priorityDate | 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.